WHO ICTRP trial
A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and…
EUCTR2008-000679-90-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-000679-90-GB |
|---|---|
| Public title | A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents aged 6-17 with Attention-Deficit/Hyperactivity Disorder (ADHD) |
| Scientific title | A Phase III, Randomised, Double-Blind, Multicentre, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimisation Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents aged 6-17 with Attention-Deficit/Hyperactivity Disorder (ADHD) |
| Primary sponsor | Shire Pharmaceutical Development Limited |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Germany;United Kingdom;Netherlands;Belgium;France;Spain;Italy;Sweden |
| Conditions | Attention Deficit / Hyperactivity Disorder (ADHD) MedDRA version: 9.1 Level: LLT Classification code 10064104 Term: ADHD |
| Interventions | Product Name: Lisdexamfetamine dimesylate (LDX) Product Code: SPD489 Pharmaceutical Form: Capsule* CAS Number: 608137-33-3 Current Sponsor code: SPD489 Other descriptive name: Lisdexamfetamine dimesylate (LDX) Concentration unit: mg… |
| Registration date | May 16, 2008 |
| Target size | 333 |
| Secondary IDs | SPD489-325 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: